Exact Sciences Corp. (NASDAQ: EXAS) filed a shelf registration statement for the sale of up to $150 million in equity, debt and warrants, according to the federal Securities and Exchange Commission.

Madison-based Exact Sciences has agreed to be acquired by Abbott Laboratory for roughly $23 billion in a deal announced Nov. 20. In 2020, Exact Sciences completed a new building for its headquarters ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Madison-based Exact Sciences, a maker and provider of cancer ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

The Beat today wouldn't be worthy of Wisconsin Inno if it didn't feature innovative companies. So here's news of the state of Wisconsin providing matching grants for companies that have won funds ...

MADISON, Wis. -- Exact Sciences is laying off 4% of its overall workforce, including 80 positions at the headquarters in Madison. Approximately 200 positions in Wisconsin will be impacted, including ...

MADISON (WKOW) -- Madison-based Exact Sciences is cutting about 4% of its overall workforce, impacting about 200 positions in Wisconsin. The company has 7,200 employees globally. An Exact Sciences ...

For a third consecutive year, a deal involving a health care-focused company is among the state’s largest mergers and... As an entrepreneur, Kevin Conroy is chairman and CEO of Exact Sciences, a ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

MADISON (WKOW) -- Abbott announced it will acquire Exact Sciences for an approximate enterprise value of $23 billion. Exact Sciences, a Madison-based company, is known for several products that focus ...